A detailed history of Center Book Partners LP transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Center Book Partners LP holds 23,794 shares of CRL stock, worth $3.99 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
23,794
Previous 3,753 534.0%
Holding current value
$3.99 Million
Previous $569,000 554.13%
% of portfolio
0.2%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025

BUY
$145.57 - $178.99 $2.92 Million - $3.59 Million
20,041 Added 534.0%
23,794 $3.72 Million
Q2 2025

Aug 12, 2025

SELL
$99.75 - $151.89 $1.02 Million - $1.56 Million
-10,272 Reduced 73.24%
3,753 $569,000
Q1 2025

May 09, 2025

SELL
$150.52 - $190.14 $1.74 Million - $2.2 Million
-11,593 Reduced 45.25%
14,025 $2.11 Million
Q4 2024

Feb 13, 2025

BUY
$178.58 - $220.69 $4.57 Million - $5.65 Million
25,618 New
25,618 $4.73 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.54B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Center Book Partners LP Portfolio

Follow Center Book Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Center Book Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Center Book Partners LP with notifications on news.